THE ASSOCIATION BETWEEN RISK OF BREAST-CANCER AND AGE AT 1ST PREGNANCY AND PARITY IN MARIBO COUNTY, DENMARK

被引：3
|
作者：
MELLEMGAARD, A
EWERTZ, M
LYNGE, E
机构：
[1] Danish Cancer Registry, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen
来源：
ACTA ONCOLOGICA | 1990年 / 29卷 / 06期
关键词：
Age at first pregnancy; Breast cancer; Parity; Reproductive factors;
D O I：
10.3109/02841869009092987
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The effect of age at first pregnancy and number of pregnancies was examined in a cohort of 14421 women where reproductive informations were collected as part of a cervical cancer screening program. A total of 352 cases occurred in the cohort. In subgroups of women defined by age at first pregnancy the relative risk of breast cancer was lower among women who were first pregnant before 25 years of age (RR = 0.85 vs 1.20). In subgroups of women defined by parity the relative risk decreased with increasing number of pregnancies from about unity among women with 0-3 pregnancies to 0.7 among women with 6 or more pregnancies. ©1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码：705 / 708
页数：4
相关论文
共 50 条
  • [21] Association between MDR1 C3435T polymorphism and risk of breast cancer
    Wang, Zhaoming
    Wang, Ting
    Bian, Jianmin
    GENE, 2013, 532 (01) : 94 - 99
  • [22] Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis
    Noel Pabalan
    Hamdi Jarjanazi
    Hilmi Ozcelik
    Breast Cancer Research and Treatment, 2013, 137 : 553 - 558
  • [23] Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis
    Pabalan, Noel
    Jarjanazi, Hamdi
    Ozcelik, Hilmi
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 553 - 558
  • [24] ORAL-ADMINISTRATION OF IDARUBICIN AS 1ST LINE CYTOSTATIC THERAPY IN PATIENTS WITH METASTASIZED BREAST-CANCER AND FAVORABLE PROGNOSIS - A TRIAL OF THE PHASE-II STUDY-GROUP OF THE ASSOCIATION FOR MEDICAL ONCOLOGY OF THE GERMAN CANCER SOCIETY
    POSSINGER, K
    WAGNER, H
    WORST, P
    QUEISSER, W
    BREMER, K
    RIECHE, K
    KLEE, M
    WESTERHAUSEN, M
    DONHUIJSENANT, R
    FRITZE, D
    EDLER, L
    STIEGELBAUER, G
    BURK, K
    ONKOLOGIE, 1991, 14 (01): : 31 - 34
  • [25] POPULATION-BASED COHORT INVESTIGATIONS OF THE RISK FOR MALIGNANT-TUMORS IN 1ST-DEGREE RELATIVES AND WIVES OF MEN WITH BREAST-CANCER
    OLSSON, H
    ANDERSSON, H
    JOHANSSON, O
    MOLLER, TR
    KRISTOFFERSSON, U
    WENNGREN, E
    CANCER, 1993, 71 (04) : 1273 - 1278
  • [26] NEOADJUVANT CHEMOTHERAPY BY MCF (MITOXANTRONE, CYCLOPHOSPHAMIDE, FLUOROURACIL) IN 40 PATIENTS WITH INTERMEDIATE STAGE OPERABLE BREAST-CANCER - 1ST RESULTS OF A PHASE-II STUDY
    LEMAIRE, M
    FOCAN, C
    DESAIVE, C
    CLOSONDEJARDIN, MT
    DUVIVIER, J
    FRIEDMAN, V
    BAUGNETMAHIEU, L
    PARIDAENS, R
    BULLETIN DU CANCER, 1992, 79 (09) : 883 - 891
  • [27] The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis
    Huang, Qiang
    Wang, Cheng
    Qiu, Lu-Jun
    Shao, Feng
    Yu, Ji-Hai
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) : 191 - 194
  • [28] PPARγ and PPARGC1B polymorphisms modify the association between phthalate metabolites and breast cancer risk
    Martinez-Nava, Gabriela A.
    Burguete-Garcia, Ana I.
    Lopez-Carrillo, Lizbeth
    Hernandez-Ramirez, Raid U.
    Madrid-Marina, Vicente
    Cebrian, Mariano E.
    BIOMARKERS, 2013, 18 (06) : 493 - 501
  • [29] The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis
    Qiang Huang
    Cheng Wang
    Lu-Jun Qiu
    Feng Shao
    Ji-Hai Yu
    Breast Cancer Research and Treatment, 2011, 129 : 191 - 194
  • [30] The association between genetic variant of MDR1 gene and breast cancer risk factors in Chinese women
    Gao, Ling
    Yang, Yijin
    Song, Shiduo
    Hong, Han
    Zhao, Xin
    Li, Dechun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 17 (01) : 88 - 91
12345